Adverse effects

Related by string. adverse effects * ADVERSE . adverse : adverse determinations . FDA MedWatch Adverse Event . adverse impacts . treatment emergent adverse . adverse reactions . adverse inference / effected . effecting . EFFECTS . Effects . EFFECT : REMAINS IN EFFECT UNTIL . Mass Effect . visual effects . chilling effect . Side Effects * xxiv adverse effects . Material Adverse Effect *

Related by context. Frequent words. (Click for all words.) 68 neutropenia thrombocytopenia 67 extrapyramidal symptoms 66 lipid lowering agents 65 Exclusion criteria 64 nausea constipation 64 concomitant medications 63 abdominal distension 63 severe hypersensitivity reactions 63 hypercholesterolaemia 63 candidemia 63 diarrhea nausea vomiting 63 corticosteroid therapy 62 moderate renal impairment 62 eosinophilia 62 neuropsychiatric symptoms 62 Nausea vomiting 62 Atopic dermatitis 61 leucopenia 61 bone marrow suppression 61 Adverse reactions 61 nausea vomiting diarrhea abdominal 61 hematologic toxicity 61 impaired cognition 61 neurologic complications 61 vasomotor symptoms 61 obstructive lung 61 immunodeficiencies 61 Allergic reactions 61 oxcarbazepine 61 hepatic dysfunction 60 HMG CoA reductase inhibitors 60 FOSRENOL ® 60 Exacerbations 60 severe renal impairment 60 antiemetics 60 tumor necrosis 60 Hypersensitivity reactions 60 predisposing factor 60 vasodilatation 60 thyroid dysfunction 60 hemoptysis 60 vaginal yeast infections 60 thyroid hormone levels 60 Glucocorticoids 60 efalizumab 60 hypophosphatemia 60 airway hyperresponsiveness 60 proliferative diabetic retinopathy 60 dyslipidaemia 60 therapeutic regimens 60 alanine aminotransferase 59 receiving VELCADE 59 Contraindications 59 hepatic failure 59 Cognitive impairment 59 bovine thrombin 59 cardiovascular disease hypertension 59 hyperalgesia 59 immunomodulation 59 TEAEs 59 lipid parameters 59 lymphadenopathy 59 coagulopathy 59 paresthesias 59 Sjögren syndrome 59 alanine aminotransferase ALT 59 serum lipids 59 osteoarthritis rheumatoid arthritis 59 folinic acid 59 retrograde ejaculation 59 squalamine 59 renal toxicity 59 hypoglycemic events 59 chills headache 59 pharmacological approaches 59 metabolic parameters 59 GnRH agonists 59 Overactive bladder 59 thorough QT 59 neurologic symptoms 59 Creatinine 59 NPH insulin 59 sociodemographic characteristics 58 hypoxemia 58 Hematologic 58 cerebrovascular diseases 58 epistaxis 58 dosing frequency 58 inflammatory autoimmune diseases 58 neurological abnormalities 58 transaminases 58 cardioprotection 58 prolactin levels 58 tibolone 58 fatigue nausea 58 NUCYNTA ® 58 allergic sensitization 58 Renal impairment 58 menstrual irregularities 58 surrogate markers 58 APTIVUS r

Back to home page